Back to Results
First PageMeta Content
Health / Stem cells / Collagen disease / Rare diseases / Epidermolysis bullosa / Stem cell treatments / Clinical trial / Recessive dystrophic epidermolysis bullosa / Cell therapy / Biology / Genodermatoses / Medicine


Reviewers for volumes 60 and 61
Add to Reading List

Document Date: 2014-12-17 09:03:23


Open Document

File Size: 108,15 KB

Share Result on Facebook

City

Tokyo / Madrid / Greensboro / /

Company

Organogenesis Inc / ConvaTec Inc / BioSolutions LLC / Alwyn Company Inc / Mitsui Norin Co Ltd / /

Country

Japan / Australia / Spain / /

/

Event

FDA Phase / /

Facility

University of Nottingham Medical School / Hospital Ni~ / Queens Medical Center / /

IndustryTerm

treatment of skin disease / tumor early diagnosis protocol / /

MedicalCondition

inflammatory pain / tumor / rare diseases / syndactyly / chronic pain / dystrophic epidermolysis bullosa / skin cancer / dystrophic epidermolysis bullosa research / skin disease / pain / epidermolysis bullosa / recessive dystrophic epidermolysis bullosa / chronic and nonchronic wounds / infection / pruritus / very rare disorders / /

MedicalTreatment

stem cell therapy / occupational therapy / antibiotics / amputations / cell therapy / surgery / physiotherapy / /

Organization

Queens Medical Center / World Health Organization / University of Nottingham Medical School / World Heath Organization / Dystrophic Epidermolysis Bullosa Research Association / Dermatology Department / Research Unit / /

Person

Paula Davila-Seijo / Ignacio Garc / Catriona Rajan / /

Position

representative for our country / Editor / Governor / /

Product

trimethoprim / sodium chloride / gabapentin / ondansetron / DEB / /

RadioStation

J AM / /

Technology

cell therapy / tissue engineering / DTD / transplantation / tumor early diagnosis protocol / /

URL

http /

SocialTag